BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brooks JI, Niznick H, Ofner M, Merks H, Angel JB. Local phylogenetic analysis identifies distinct trends in transmitted HIV drug resistance: implications for public health interventions. BMC Infect Dis 2013;13:509. [PMID: 24171696 DOI: 10.1186/1471-2334-13-509] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
Number Citing Articles
1 Hassan AS, Esbjörnsson J, Wahome E, Thiong'o A, Makau GN, Price MA, Sanders EJ. HIV-1 subtype diversity, transmission networks and transmitted drug resistance amongst acute and early infected MSM populations from Coastal Kenya. PLoS One 2018;13:e0206177. [PMID: 30562356 DOI: 10.1371/journal.pone.0206177] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
2 Vrancken B, Adachi D, Benedet M, Singh A, Read R, Shafran S, Taylor GD, Simmonds K, Sikora C, Lemey P, Charlton CL, Tang JW. The multi-faceted dynamics of HIV-1 transmission in Northern Alberta: A combined analysis of virus genetic and public health data. Infect Genet Evol 2017;52:100-5. [PMID: 28427935 DOI: 10.1016/j.meegid.2017.04.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
3 Wheeler J, Chan S, Harrigan PR, Becker M, Kasper K, Keynan Y. Dolutegravir with boosted darunavir treatment simplification for the transmitted HIV thymidine analog resistance in Manitoba, Canada. Int J STD AIDS 2018;29:520-2. [PMID: 29513131 DOI: 10.1177/0956462418760426] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Bbosa N, Ssemwanga D, Nsubuga RN, Kiwanuka N, Bagaya BS, Kitayimbwa JM, Ssekagiri A, Yebra G, Kaleebu P, Leigh-Brown A. Phylogenetic Networks and Parameters Inferred from HIV Nucleotide Sequences of High-Risk and General Population Groups in Uganda: Implications for Epidemic Control. Viruses 2021;13:970. [PMID: 34073846 DOI: 10.3390/v13060970] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Fujimoto K, Paraskevis D, Kuo JC, Hallmark CJ, Zhao J, Hochi A, Kuhns LM, Hwang LY, Hatzakis A, Schneider JA. Integrated molecular and affiliation network analysis: Core-periphery social clustering is associated with HIV transmission patterns. Soc Networks 2022;68:107-17. [PMID: 34262236 DOI: 10.1016/j.socnet.2021.05.003] [Reference Citation Analysis]
6 Chin BS, Shin HS, Kim G, Wagner GA, Gianella S, Smith DM. Short Communication: Increase of HIV-1 K103N Transmitted Drug Resistance and Its Association with Efavirenz Use in South Korea. AIDS Res Hum Retroviruses 2015;31:603-7. [PMID: 25826122 DOI: 10.1089/AID.2014.0368] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
7 Mehta SR, Schairer C, Little S. Ethical issues in HIV phylogenetics and molecular epidemiology. Curr Opin HIV AIDS 2019;14:221-6. [PMID: 30946143 DOI: 10.1097/COH.0000000000000538] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
8 Yuan D, Liu M, Li Y, Jia P, Su L, Ye L, Zhang Y, Ling P, Zhou C, Liang S, Yang H, Liu H, Yang S. Genetic transmission networks of HIV-1 CRF07_BC strain among HIV-1 infections with virologic failure of ART in a minority area of China: a population-based study. BMC Infect Dis 2020;20:631. [PMID: 32842977 DOI: 10.1186/s12879-020-05347-2] [Reference Citation Analysis]
9 Yuan D, Yu B, Li Y, Wang Z, Liu M, Ye L, Huang Y, Su L, Zhang Y, Api L, Chen M, Zhou C, Liu L, Zhang L, Liang S, Jia P, Yang S. Prevalence and Molecular Epidemiology of Transmitted Drug Resistance and Genetic Transmission Networks Among Newly Diagnosed People Living With HIV/AIDS in a Minority Area, China. Front Public Health 2021;9:731280. [PMID: 34708015 DOI: 10.3389/fpubh.2021.731280] [Reference Citation Analysis]